0.411
0.019 (4.85%)
0.019 (4.85%)
Upgrade to Real-Time
Afterhours (Closed)
| Volume | 1,407,367 |
|
|||||
| News | - | ||||||
| Day High | 0.42 | Low High |
|||||
| Day Low | 0.38 | ||||||
Best deals to access real time data! |
|
CHART Trader
Monthly Subscription
for only
|
|
Canadian Level 1 + USA
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Regulus Therapeutics Inc | RGLS | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
 |
|
|---|---|---|---|---|
| 0.019 | 4.85% | 0.411 | 17:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 0.39 | 0.38 | 0.42 | 0.411 | 0.392 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 1,494 | 1,407,367 | $ 0.3997953 | $ 562,659 | - | 0.34045 - 2.32 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 16:57:01 | formt | 2,000 | $ 0.416 | USD |
Period:
Draw Mode:
Regulus Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 35.78M | 87.05M | 73.06M | $ 10.01M | $ -7.99M | -0.50 | -1.60 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | - | - | 4.10% |
Regulus Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical RGLS Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.386 | 0.42 | 0.34045 | 0.371384 | 1,421,697 | 0.025 | 6.48% |
| 1 Month | 0.46 | 0.514 | 0.34045 | 0.4392845 | 1,673,138 | -0.049 | -10.65% |
| 3 Months | 0.83 | 0.8522 | 0.34045 | 0.532914 | 2,042,777 | -0.419 | -50.48% |
| 6 Months | 0.95 | 1.48 | 0.34045 | 0.7987282 | 2,502,391 | -0.539 | -56.74% |
| 1 Year | 0.6142 | 2.32 | 0.34045 | 1.22 | 2,843,307 | -0.2032 | -33.08% |
| 3 Years | 1.51 | 2.32 | 0.34045 | 1.10 | 1,344,052 | -1.10 | -72.78% |
| 5 Years | 33.60 | 36.12 | 0.34045 | 4.05 | 1,126,711 | -33.19 | -98.78% |
Regulus Therapeutics Description
| Regulus Therapeutics Inc is a biotechnology company focused on the development of microRNA therapies. MicroRNA therapies target diseases such as cancer, metabolic diseases, fibrosis, and inflammatory diseases. MicroRNA is a noncoding ribonucleic acid that regulates most genes in the genome. The company partnered with Sanofi to create a compound targeting orphan diseases and with AstraZeneca to cure Type 2 Diabetes/prediabetes. |
